Quince Therapeutics, Inc. (QNCX)
DATE
INSIDER
COMPANY
OWNED SHARES
SHARES TRADED
PRICE
NET TOTAL
BUY
24 Mar 2021
Lamond David
Director
Cortexyme, Inc.
(CRTX)
1,847,109+2%
50,000
$33.77
$1,688,500.00
BUY
4 Mar 2021
Lamond David
Director
Cortexyme, Inc.
(CRTX)
1,763,730+2%
50,000
$35.34
$1,767,057.20
BUY
4 Jun 2020
Lamond David
Director
Cortexyme, Inc.
(CRTX)
1,711,593+2%
49,125
$43.27
$2,125,795.00
SELL
3 Jun 2020
PFIZER INC
10% Owner
Cortexyme, Inc.
(CRTX)
2,879,973-11%
370,000
$40.18
$14,866,600.00
BUY
15 May 2020
Lamond David
Director
Cortexyme, Inc.
(CRTX)
1,659,184+2%
44,648
$55.35
$2,471,251.20
BUY
13 May 2019
PFIZER INC
10% Owner
Cortexyme, Inc.
(CRTX)
3,249,973+1%
50,000
$17.00
$850,000.00
BUY
13 May 2019
YOUNG KEVIN
Director
Cortexyme, Inc.
(CRTX)
30,000+100%
30,000
$17.00
$510,000.00
Home